Bard Boosts R&D, Scans Acquisition Targets To Buck Historical Growth Trend

Bard will draw on $463 mil. in cash and short-term investments to support an aggressive business development strategy aimed at raising top-line revenue beyond its traditional 7%-10% annual growth rate

More from Archive

More from Medtech Insight